ANE Logistics

ANE is a leading express freight network in China’s less-than-truckload (“LTL”) market. As of December 31, 2024, ANE had 82 self-operated sorting centres across China, covering approximately 99.3% of the counties and townships.

The company mainly provides transportation services, value-added services and dispatch services to its freight partners, its direct customers. Together with its freight partners and agents, ANE served over 6.3 million shippers, its end-customers, across China as of December 31, 2024.

Arion Cancer Hospital

Arion is a private tertiary cancer hospital in Beijing, jointly founded and invested by Amcare Group, Centurium Capital and other financial/strategic investors. Dedicated to personalized full-cycle cancer treatments and management, from prevention and early test of symptoms, to adoption of most advanced cancer treatment methods, the hospital brings globally-leading treatment skills, concept and talents to cancer patients in China.

Located in Daxing District in South Beijing, Arion Cancer Hospital covers an area of over 24,000 square meters with 400 beds for inpatients, including 60 day-time beds for chemotherapy and 24 ICU/emergency beds.

Fadada

Fadada is a leading e-signature and cloud contract service provider in China. The company offers a full suite of e-signature products including one-stop SaaS products, open API solutions for corporate IT and ERP systems, as well as hybrid cloud solutions for local hosting of electronic contracts and process management.

Fadada is a pioneer in legal technology innovation. It was the earliest provider of block-chain based e-signature product with enhanced security features and credibility. It pioneered in building an industry-leading e-contract management system, which significantly improved the efficiency of the legal process involved in contract signing. It was the first to enable online data sharing and connection with judiciary bodies, including online arbitration institutions, online courtroom, notary offices and forensic evaluation centers, providing one of the most complete technology solutions for online dispute resolutions in China.

Fadada’s products are ISO27001 and ISO27018 accredited and its clients include leading Chinese and global corporates such as Tencent, Microsoft (China), Bytedance, Alibaba, Oracle, Meituan, Ctrip, Yuexiu Real Estate, Poly Real Estate, Xugong Group, Fesco, China Telecom, Haidilao, New Oriental Education and Xiao Hong Shu.

Gaussian Robotics

Founded in 2013, Gaussian Robotics is a technology driven company focusing on SLAM (“Simultaneous Localization And Mapping”) application and development. Gaussian Robotics is a pioneer and leader in the enterprise-level AMR (“autonomous mobile robots”) cleaning robotics space with six key products covering seven major cleaning functions.

Gaussian Robotics is the only cleaning robotics company with ISO9001, Chinese robotics CR, U.S. UL safety and Europe CE safety certificates. Up to date, Gaussian Robotics has provided services to more than 2,000 customers globally, equivalent of over 200 million kilometers of cleaning distance.  

Driven by self-developed AMR technologies applicable for all scenarios and full stack, Gaussian Robotics offers integrated manufacturing, research, development, sales and services to its customers. Gaussian Robotics is committed to transform the traditional services industry into the new era of intelligent services powered by robotics technology.

GOUMEE

GOUMEE is a tech-driven online brand operation and marketing service provider in fashion industry. It focuses on live-streaming e-commerce operation and influencer marketing, helping brands to acquire customers in new traffic channels and developing new products. GOUMEE is a first-tier live-streaming e-commerce Douyin Partner and a top notch service provider in both T-mall and Douyin.

Innogen

Shanghai Innogen Pharmaceutical Technology Co., Ltd.  is a science-driven biotechnology company dedicated to the research and development of innovative and affordable medicines for diabetes and other metabolic disease patients. Innogen’s pipeline in metabolic disease, including Type 1 & 2 diabetes, obesity and NASH, is independently developed and has global market rights.

Supaglutide, the company’s first pipeline product, Efsubaglutide Alfa (previously named as Supaglutide, with trade name: DiabegoneTM ), was approved by the NMPA in January, 2025. It is the first humanized long-acting GLP-1 drug that originated from China, which will benefit more diabetes patients. Other indications for Efsubaglutide Alfa such as obesity and MASH are also under development to address the large unmet therapeutic needs in these disease areas.

Kidswant

Kidswant is a leading mother-infant-children (MIC) service brand and retailer in China providing family products and services. Through its mega stores and online e-commerce platforms, Kidswant services millions of Chinese families. The company differentiates itself with its large team of professional children nurturing consultants, who provide real-time and personalized counsel to customers.

Founded in 2019, Kidswant provides one-stop services to expectant mothers and 0-14 year-old children, driven by its strong customer relationship management system. Committed to continuous improvement of children’s growth and living standards, Kidswant has become one of the top service providers for China’s new families.

Laso Biotech

Suzhou LASO Biotech is the first company in China for the proprietary development, production, and commercialization of microarray technology platform, providing an integrated solution including chips (customizable), the OmniScan device, reagents, softwares and algorithms.

As of now, Laso Biotech has obtained 13 invention patents, 5 utility model patents, 3 design patents, and 1 medical device registration certificate, making it the company with the most comprehensive intellectual property portfolio and independently controllable core technologies for microarray under Chinese law.

LOHO

Founded in 2011 in Shenzhen, China, LOHO is the first O2O fashion glasses retail platform in China. The M2C mode firstly launched by LOHO has broken the industrial monopoly and created a mode that directly connects manufacturing to end-user. It cuts the cost of intermediate links and gains an absolute advantage in cost and price.

The LOHO platform provides updates on a daily basis, offering products with various designs and SKU to meet the needs of different consumer groups and scenarios.

The LOHO products are designed by world’s first class brand designers, and is committed to bring young consumers highly cost-effective and stylish glasses and experiences. LOHO has had several hundreds of stores nationwide in China, covering core business areas in more than 100 cities including Beijing, Shanghai, Guangzhou, Shenzhen, Nanjing, Chongqing, Chengdu and Changsha.

Luckin Coffee

Luckin Coffee (OTC: LKNCY) is the pioneer of a technology-driven new retail model to provide coffee and other products of high quality, high affordability, and high convenience to customers. Its mission is to be part of everyone’s everyday life, starting with coffee. As of March 31, 2025, Luckin operates 24,097 stores in China and Singapore.

Luckin’s online-offline model is built upon its mobile and store networks. Its mobile app and presence on other third-party platforms cover the entire customer purchase process, offering customers a 100% cashier-less environment. This enhances its customer experience, improves its operating efficiency, and allows it to stay connected with customers and engage with them anytime, anywhere. Luckin’s store network is comprised of pick-up stores, relax stores, and delivery kitchens, which enable the company to maximize convenience for its customers, improve its brand recognition, and achieve broader delivery coverage.

Luckin Coffee was founded in 2017 and is based in Xiamen, China.